Reuters
Reuters
Amgen Inc's closely watched new cholesterol drug, Repatha, has been recommended for approval in Europe, putting the U.S. drugmaker ahead in a race with rival Sanofi SA. Repatha, or evolocumab, belongs to a new class of cholesterol-lowering drugs ...
Amgen's Cholesterol Drug Recommended by European Regulator Panel Bloomberg
Amgen Receives Positive CHMP Opinion For Use Of Repatha™ (Evolocumab ... PR Newswire (press release)
all 16 news articles »
from @ Health and Medical News http://ift.tt/1c9k8tr
via Health and Medical NewsHealth and Medical News Pfizer Inc has already had its takeover overtures rebuffed three times by rival AstraZeneca Plc, but investors in the U.S. drugmaker say it can tolerate a little more rejection before going hostile with the deal. AstraZeneca turned down a sweeten...
